• 

  December 22, 2025

  Rybrevant (Amivantamab) Treatment of EGFR Positive Non-Small Cell Lung Cancer

  Charles H. Weaver, MD

• 

  August 28, 2025

  In Depth Overview of Tyrosine Kinase Inhibitor Treatment of EGFR + Lung Cancer

  Charles H. Weaver, MD

• 

  September 12, 2024

  Ivonescimab Shows Promising Results for Advanced NSCLC

  Charles H. Weaver, MD

• 

  September 14, 2023

  Lumakras (sotorasib,AMG 510) Precision Cancer Medicine Targets KRAS NSCLC

  Charles H. Weaver, MD

• 

  March 24, 2021

  Keytruda in Non-Small Cell Lung Cancer

  Charles H. Weaver, MD

• 

  February 17, 2021

  Treatment & Management of Non Small Cell Lung Cancer

  Charles H. Weaver, MD

• 

  February 6, 2021

  Treatment of Stage III B – IV Non-Small Cell Lung Cancer

  Charles H. Weaver, MD

• 

  January 31, 2021

  Mobocertinib Treatment for Non-Small Cell Lung Cancer with exon 20 Mutations

  Charles H. Weaver, MD

• 

  November 2, 2019

  Treatment of Recurrent Non-Small Cell Lung Cancer

  Charles H. Weaver, MD